The Pulmonary/Respiratory Drug Delivery market was valued at USD 64.03 Million in 2024 and is expected to reach USD 105.98 Million by 2032, growing at a CAGR of 6.5% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.